Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathwaysBo Zhou, Gang Chen|International Journal of Oncology|2016Cited by 109
Targeting EGFR/HER2 heterodimerization with a novel anti-HER2 domain II/III antibodyXiaojie Yu, Bohua Li, Yajun Zhang et al.|Molecular Immunology|2017Cited by 23
Tolerability, pharmacokinetics and pharmacodynamics of CMAB007, a humanized anti-immunoglobulin E monoclonal antibody, in healthy Chinese subjectsBo Zhou, Yajun Guo, Birong Lin et al.|mAbs|2012Cited by 16